Home › Glioma › Ohio › Columbus
Glioma clinical trials in Columbus, OH
15 studies for Glioma are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RecruitingPhase 1/2
- Nationwide Children's Hospital, Columbus
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- Ohio State University, Columbus
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RecruitingPhase 2
- Nationwide Children's Hospital, Columbus
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Nationwide Children's Hospital, Columbus
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Nationwide Children's Hospital, Columbus
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- Nationwide Children's Hospital, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Recruiting
- Ohio State University Medical Center, Columbus
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RecruitingPhase 1/2
- Nationwide Children's Hospital, Columbus
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Nationwide Children's Hospital, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Nationwide Children's Hospital, Columbus
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
RecruitingPhase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RecruitingPhase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
RecruitingEarly phase 1
- Nationwide Children's Hospital, Columbus
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
RecruitingPhase 1
- Nationwide Children's Hospital, Columbus
Glioma trials in other cities
- New York City, NY25 studies
- Houston, TX23 studies
- Boston, MA20 studies
- Washington, DC19 studies
- Philadelphia, PA16 studies
- Miami, FL15 studies
- San Francisco, CA14 studies
- Chicago, IL13 studies
- Durham, NC12 studies
- Seattle, WA11 studies
- Los Angeles, CA10 studies
- St. Louis, MO10 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.